<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38479688</PMID><DateCompleted><Year>2024</Year><Month>05</Month><Day>03</Day></DateCompleted><DateRevised><Year>2025</Year><Month>02</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-2190</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>5</Issue><PubDate><Year>2024</Year><Month>May</Month></PubDate></JournalIssue><Title>Actas dermo-sifiliograficas</Title><ISOAbbreviation>Actas Dermosifiliogr</ISOAbbreviation></Journal><ArticleTitle>[Translated article] Spanish Academy of Dermatology and Venereology (AEDV) expert recommendations for the management of sexual transmitted parasitosis. Scabies, and pediculosis pubis.</ArticleTitle><Pagination><StartPage>T475</StartPage><EndPage>T492</EndPage><MedlinePgn>T475-T492</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ad.2024.03.016</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0001-7310(24)00204-7</ELocationID><Abstract><AbstractText>Sexually transmitted infections are communicable diseases where the pathogen is transmitted through sexual contact. The Sexually Transmitted Infections Working Group of the Spanish Academy of Dermatology and Venereology (AEDV) is engaged in the drafting of documents to guide dermatologists and health care personnel who treat Spanish patients with these infections. This document analyzes the epidemiological, clinical, therapeutic, and control characteristics of 2 sexually transmitted parasitosis: scabies due to Sarcoptes scabiei var. hominis, and pubic pediculosis due to Phthirus pubis. Both parasitoses share a sort of mixed spread through sexual and community transmission regardless of the route through which the infection was initially acquired. This specific feature creates particularities in the management and control of the infestation.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 AEDV. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Galv&#xe1;n-Casas</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Unidad Skin Neglected Tropical Diseases and Sexually Transmitted Infections; Fundaci&#xf3; Lluita contra les Infeccions, Badalona, Barcelona, Spain; Servicio de Dermatolog&#xed;a, Hospital Universitario de M&#xf3;stoles, M&#xf3;stoles, Madrid, Spain. Electronic address: galvancasascristina@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortiz-&#xc1;lvarez</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Universitario Virgen del Roc&#xed;o, Sevilla, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mart&#xed;nez-Garc&#xed;a</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Virgen de la Victoria, M&#xe1;laga, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Corbacho-Monn&#xe9;</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Universitari Parc Taul&#xed;, Sabadell, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D017065">Practice Guideline</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Actas Dermosifiliogr</MedlineTA><NlmUniqueID>0373062</NlmUniqueID><ISSNLinking>0001-7310</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012532" MajorTopicYN="Y">Scabies</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010373" MajorTopicYN="Y">Lice Infestations</DescriptorName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012749" MajorTopicYN="N">Sexually Transmitted Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020061" MajorTopicYN="N">Phthirus</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Crab louse</Keyword><Keyword MajorTopicYN="N">Escabiosis</Keyword><Keyword MajorTopicYN="N">ITS</Keyword><Keyword MajorTopicYN="N">Infecciones de transmisi&#xf3;n sexual</Keyword><Keyword MajorTopicYN="N">Ladillas</Keyword><Keyword MajorTopicYN="N">Pediculosis pubis</Keyword><Keyword MajorTopicYN="N">Pediculosis p&#xfa;bica</Keyword><Keyword MajorTopicYN="N">STI</Keyword><Keyword MajorTopicYN="N">Sarna</Keyword><Keyword MajorTopicYN="N">Scabies</Keyword><Keyword MajorTopicYN="N">Sexually transmitted infections</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>10</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>5</Month><Day>4</Day><Hour>11</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>14</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>13</Day><Hour>20</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38479688</ArticleId><ArticleId IdType="doi">10.1016/j.ad.2024.03.016</ArticleId><ArticleId IdType="pii">S0001-7310(24)00204-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37923075</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>05</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>20</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-2190</ISSN><JournalIssue CitedMedium="Internet"><Volume>115</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Actas dermo-sifiliograficas</Title><ISOAbbreviation>Actas Dermosifiliogr</ISOAbbreviation></Journal><ArticleTitle>[Translated article] Scabies in Spain: Trends in Public Interest and Ectoparasiticide Use.</ArticleTitle><Pagination><StartPage>T76</StartPage><EndPage>T79</EndPage><MedlinePgn>T76-T79</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ad.2023.10.034</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0001-7310(23)00868-2</ELocationID><Abstract><AbstractText>Scabies is an ectoparasitic dermatosis caused by the Sarcoptes scabiei var. hominis mite, which lives and reproduces in humans. Its incidence in Spain has increased in recent years. The aim of this study was to complement existing evidence on the increasing number of scabies cases in our country by analyzing changes in ectoparasiticide prescriptions and Internet searches for scabies infestations measured by Google Trends. We also examined correlations between these two variables. Our results show that public interest in scabies has increased in recent years and is positively and significantly correlated with an increasing use of ectoparasiticides. We believe that Google Trends should be considered as a complementary tool for monitoring real-time trends in scabies infestations in Spain.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 AEDV. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Fern&#xe1;ndez Camporro</LastName><ForeName>&#xc1;</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Universitario de Cabue&#xf1;es, Gij&#xf3;n, Asturias, Spain; Departamento de Medicina, Universidad de Oviedo, Oviedo, Spain. Electronic address: angelderma95@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navarro Fern&#xe1;ndez</LastName><ForeName>&#xcd;</ForeName><Initials>&#xcd;</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Universitario de Cabue&#xf1;es, Gij&#xf3;n, Asturias, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arcos Gonz&#xe1;lez</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Departamento de Medicina, Universidad de Oviedo, Oviedo, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Actas Dermosifiliogr</MedlineTA><NlmUniqueID>0373062</NlmUniqueID><ISSNLinking>0001-7310</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012520" MajorTopicYN="N">Sarcoptes scabiei</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012532" MajorTopicYN="Y">Scabies</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemiology</Keyword><Keyword MajorTopicYN="N">Epidemiolog&#xed;a</Keyword><Keyword MajorTopicYN="N">Escabiosis</Keyword><Keyword MajorTopicYN="N">Google Trends</Keyword><Keyword MajorTopicYN="N">Infodemiology</Keyword><Keyword MajorTopicYN="N">Infodemiolog&#xed;a</Keyword><Keyword MajorTopicYN="N">Inter&#xe9;s p&#xfa;blico</Keyword><Keyword MajorTopicYN="N">Mites</Keyword><Keyword MajorTopicYN="N">Public interest</Keyword><Keyword MajorTopicYN="N">Sarna</Keyword><Keyword MajorTopicYN="N">Scabies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>3</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>3</Day><Hour>20</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37923075</ArticleId><ArticleId IdType="doi">10.1016/j.ad.2023.10.034</ArticleId><ArticleId IdType="pii">S0001-7310(23)00868-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">37068634</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2025</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-2190</ISSN><JournalIssue CitedMedium="Internet"><Volume>114</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Actas dermo-sifiliograficas</Title><ISOAbbreviation>Actas Dermosifiliogr</ISOAbbreviation></Journal><ArticleTitle>[Translated article] RF - Resistance to Permethrin in Scabies Treatment: Does It Really Exist?</ArticleTitle><Pagination><StartPage>T433</StartPage><EndPage>T434</EndPage><MedlinePgn>T433-T434</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ad.2022.05.046</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0001-7310(23)00289-2</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Velasco-Amador</LastName><ForeName>J P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Universitario San Cecilio, Inst. Invest. Biosanitaria IBS Granada, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prados-Carmona</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Universitario San Cecilio, Inst. Invest. Biosanitaria IBS Granada, Granada, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruiz-Villaverde</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Universitario San Cecilio, Inst. Invest. Biosanitaria IBS Granada, Granada, Spain. Electronic address: ismenios@hotmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Actas Dermosifiliogr</MedlineTA><NlmUniqueID>0373062</NlmUniqueID><ISSNLinking>0001-7310</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>509F88P9SZ</RegistryNumber><NameOfSubstance UI="D026023">Permethrin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004351" MajorTopicYN="N">Drug Resistance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026023" MajorTopicYN="Y">Permethrin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012532" MajorTopicYN="Y">Scabies</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012520" MajorTopicYN="N">Sarcoptes scabiei</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Epidemia</Keyword><Keyword MajorTopicYN="N">Epidemic</Keyword><Keyword MajorTopicYN="N">Escabiosis</Keyword><Keyword MajorTopicYN="N">Permethrin</Keyword><Keyword MajorTopicYN="N">Permetrina</Keyword><Keyword MajorTopicYN="N">Sarcoptes scabiei</Keyword><Keyword MajorTopicYN="N">Sarna</Keyword><Keyword MajorTopicYN="N">Scabies</Keyword><Keyword MajorTopicYN="N">Tratamiento</Keyword><Keyword MajorTopicYN="N">Treatment</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>1</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>23</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>17</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37068634</ArticleId><ArticleId IdType="doi">10.1016/j.ad.2022.05.046</ArticleId><ArticleId IdType="pii">S0001-7310(23)00289-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35051892</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-1275</ISSN><JournalIssue CitedMedium="Internet"><Volume>54</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Atencion primaria</Title><ISOAbbreviation>Aten Primaria</ISOAbbreviation></Journal><ArticleTitle>[Treatment of scabies].</ArticleTitle><Pagination><StartPage>102231</StartPage><MedlinePgn>102231</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">102231</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.aprim.2021.102231</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0212-6567(21)00265-1</ELocationID><Abstract><AbstractText>Scabies affects more than 200 million people around the world, and causes a significant socioeconomic impact. Prolonged skin-to-skin contact is the primary mode of transmission. Fomite-mediated transmission is uncommon, although it can be significant in crusted scabies. Topical therapy with permethrin 5% is recommended as first-line treatment. It can be indicated during pregnancy and lactation, and appears to be safe in children &lt;2 months. However, a decrease in the effectiveness of this drug has recently been reported. Another first-line therapeutic alternative is oral ivermectin. It can be administered during lactation, and new evidence suggests that it is safe in children &gt;15kg. Diverse systematic reviews and meta-analysis have concluded that oral ivermectin is as effective and safe as topical permethrin. Mass drug administration of oral ivermectin is an excellent option for the management of scabies in communities with high prevalence, or for scabies outbreaks in institutions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morgado-Carrasco</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital de Figueres, Fundaci&#xf3; Salut Empord&#xe0;, Figueres, Girona, Espa&#xf1;a; Servicio de Dermatolog&#xed;a, Hospital Cl&#xed;nic de Barcelona, Universitat de Barcelona, Barcelona, Espa&#xf1;a. Electronic address: morgadodaniel8@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piquero-Casals</LastName><ForeName>Jaime</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Dermik. Cl&#xed;nica Dermatol&#xf3;gica Multidisciplinar, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Podlipnik</LastName><ForeName>Sebastian</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Cl&#xed;nic de Barcelona, Universitat de Barcelona, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>Tratamiento de la escabiosis.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Aten Primaria</MedlineTA><NlmUniqueID>9111075</NlmUniqueID><ISSNLinking>0212-6567</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D007306">Insecticides</NameOfSubstance></Chemical><Chemical><RegistryNumber>509F88P9SZ</RegistryNumber><NameOfSubstance UI="D026023">Permethrin</NameOfSubstance></Chemical><Chemical><RegistryNumber>70288-86-7</RegistryNumber><NameOfSubstance UI="D007559">Ivermectin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007306" MajorTopicYN="Y">Insecticides</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007559" MajorTopicYN="N">Ivermectin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015201" MajorTopicYN="N">Meta-Analysis as Topic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D026023" MajorTopicYN="N">Permethrin</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012532" MajorTopicYN="Y">Scabies</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText>La escabiosis afecta a m&#xe1;s de 200 millones de personas en el mundo, y ocasiona un importante impacto socioecon&#xf3;mico. El mecanismo de contagio es por contacto directo prolongado. El contagio por f&#xf3;mites es infrecuente, aunque puede ser importante en la sarna noruega. La terapia con permetrina t&#xf3;pica al 5% es recomendada como tratamiento de primera l&#xed;nea. Puede indicarse durante el embarazo y la lactancia, y parece ser segura en ni&#xf1;os &lt;&#xa0;2 meses. Sin embargo, &#xfa;ltimamente se ha reportado una disminuci&#xf3;n de la efectividad de este f&#xe1;rmaco. Otra alternativa en primera l&#xed;nea terap&#xe9;utica es la ivermectina oral. Se puede administrar durante la lactancia, y estudios recientes sugieren que es segura en ni&#xf1;os y lactantes peque&#xf1;os. Diversas revisiones sistem&#xe1;ticas y metaan&#xe1;lisis han concluido que la ivermectina oral es tan efectiva y segura como la permetrina t&#xf3;pica. La administraci&#xf3;n terap&#xe9;utica &#xab;en masa&#xbb; de ivermectina oral es una excelente opci&#xf3;n para el manejo de escabiosis en comunidades con alta prevalencia o de brotes en instituciones.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Escabiosis</Keyword><Keyword MajorTopicYN="N">Ivermectin</Keyword><Keyword MajorTopicYN="N">Ivermectina</Keyword><Keyword MajorTopicYN="N">Permetrin</Keyword><Keyword MajorTopicYN="N">Permetrina</Keyword><Keyword MajorTopicYN="N">Sarna</Keyword><Keyword MajorTopicYN="N">Scabies</Keyword><Keyword MajorTopicYN="N">Scabs</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>20</Hour><Minute>29</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35051892</ArticleId><ArticleId IdType="pmc">PMC8783089</ArticleId><ArticleId IdType="doi">10.1016/j.aprim.2021.102231</ArticleId><ArticleId IdType="pii">S0212-6567(21)00265-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Salavastru C.M., Chosidow O., Boffa M.J., Janier M., Tiplica G.S. European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017;31:1248&#x2013;1253.</Citation><ArticleIdList><ArticleId IdType="pubmed">28639722</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas C., Coates S.J., Engelman D., Chosidow O., Chang A.Y. Part I - Ectoparasites: Scabies. J Am Acad Dermatol. 2019;82:533&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">31310840</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunderk&#xf6;tter C., Aebischer A., Neufeld M., L&#xf6;ser C., Kreuter A., Bialek R., et al. Increase of scabies in Germany and development of resistant mites? Evidence and consequences. J Dtsch Dermatol Ges. 2019;1:15&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">30480868</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyersburg D., Kaiser A., Bauer J.W. &#xab;Loss of efficacy of topical 5% permethrin for treating scabies: An Austrian single-center study&#xbb;. J Dermatolog Treat. 2020 doi: 10.1080/09546634.2020.1774489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09546634.2020.1774489</ArticleId><ArticleId IdType="pubmed">32495666</ArticleId></ArticleIdList></Reference><Reference><Citation>Executive Committee of Guideline for the Diagnosis and Treatment of Scabies Guideline for the diagnosis and treatment of scabies in Japan (third edition): Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. J Dermatol. 2017;44:991&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pubmed">28561292</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernigaud C., Fernando D.D., Lu H., Taylor S., Hartel G., Chosidow O., et al. How to eliminate scabies parasites from fomites: A high-throughput ex vivo experimental study. J Am Acad Dermatol. 2020;83:241&#x2013;245.</Citation><ArticleIdList><ArticleId IdType="pubmed">31857110</ArticleId></ArticleIdList></Reference><Reference><Citation>Sunderk&#xf6;tter C., Feldmeier H., F&#xf6;lster-Holst R., Geisel B., Klinke-Rehbein S., Nast A., et al. S1 guidelines on the diagnosis and treatment of scabies - short version. J Dtsch Dermatol Ges. 2016;14:1155&#x2013;1167.</Citation><ArticleIdList><ArticleId IdType="pubmed">27879074</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC - Scabies - Resources for Health Professionals - Medications 2019. [consultado 7 Jul 2021] Disponible en: https://www.cdc.gov/parasites/scabies/health_professionals/meds.html</Citation></Reference><Reference><Citation>Hamm H., Beiteke U., H&#xf6;ger P.H., Seitz C.S., Thaci D., Sunderk&#xf6;tter C. Treatment of scabies with 5% permethrin cream: Results of a German multicenter study. J Dtsch Dermatol Ges. 2006;4:407&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pubmed">16686608</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosumeck S., Nast A., Dressler C. Evaluation of Ivermectin vs Permethrin for Treating Scabies-Summary of a Cochrane Review. JAMA Dermatol. 2019;155:730&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pubmed">31017622</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazzatenta C., Piccolo V., Argenziano G., Bassi A. Is Scabies becoming less sensitive to permethrin therapy? J Eur Acad Dermatol Venereol. 2021;35:e607&#x2013;e609.</Citation><ArticleIdList><ArticleId IdType="pubmed">33974300</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestri R., Magnano M., Infusino S.D., Rizzoli L., Girardelli C.R., Rech G. Scabies is becoming less sensitive to permethrin therapy. J Eur Acad Dermatol Venereol. 2021 doi: 10.1111/jdv.17538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jdv.17538</ArticleId><ArticleId IdType="pubmed">34310767</ArticleId></ArticleIdList></Reference><Reference><Citation>Walton S.F., Myerscough M.R., Currie B.J. Studies in vitro on the relative efficacy of current acaricides for Sarcoptes scabiei var. hominis. Trans R Soc Trop Med Hyg. 2000;94:92&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">10748911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemecek R., Stockbauer A., Lexa M., Poeppl W., Mooseder G. Application errors associated with topical treatment of scabies: An observational study. J Dtsch Dermatol Ges. 2020;18:554&#x2013;559.</Citation><ArticleIdList><ArticleId IdType="pubmed">32469466</ArticleId></ArticleIdList></Reference><Reference><Citation>Thadanipon K., Anothaisintawee T., Rattanasiri S., Thakkinstian A., Attia J. Efficacy and safety of antiscabietic agents: A systematic review and network meta-analysis of randomized controlled trials. J Am Acad Dermatol. 2019;80:1435&#x2013;1444.</Citation><ArticleIdList><ArticleId IdType="pubmed">30654070</ArticleId></ArticleIdList></Reference><Reference><Citation>Levy M., Martin L., Bursztejn A.-C., Chiaverini C., Miquel J., Mah&#xe9; E., et al. Ivermectin safety in infants and children under 15&#xa0;kg treated for scabies: A multicentric observational study. Br J Dermatol. 2020;182:1003&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pubmed">31344258</ArticleId></ArticleIdList></Reference><Reference><Citation>Mounsey K.E., Bernigaud C., Chosidow O., McCarthy J.S. Prospects for Moxidectin as a New Oral Treatment for Human Scabies. PLoS Negl Trop Dis. 2016;10:e0004389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4795782</ArticleId><ArticleId IdType="pubmed">26985995</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora P., Rudnicka L., Sar-Pomian M., Wollina U., Jafferany M., Lotti T., et al. Scabies: A comprehensive review and current perspectives. Dermatol Ther. 2020;33:e13746.</Citation><ArticleIdList><ArticleId IdType="pubmed">32484302</ArticleId></ArticleIdList></Reference><Reference><Citation>Mytton O.T., McGready R., Lee S.J., Roberts C.H., Ashley E.A., Carrara V.I., et al. Safety of benzyl benzoate lotion and permethrin in pregnancy: A retrospective matched cohort study. BJOG. 2007;114:582&#x2013;587.</Citation><ArticleIdList><ArticleId IdType="pubmed">17439567</ArticleId></ArticleIdList></Reference><Reference><Citation>Weill A., Bernigaud C., Mokni M., Gil S., Elefant E., Chosidow O. Scabies-infested pregnant women: A critical therapeutic challenge. PLoS Negl Trop Dis. 2021;15:e0008929.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7790223</ArticleId><ArticleId IdType="pubmed">33411710</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas P., Maia M.F., Bassat Q., Kobylinski K.C., Monteiro W., Rabinovich N.R., et al. Safety of oral ivermectin during pregnancy: A systematic review and meta-analysis. Lancet Glob Health. 2020;8:e92&#x2013;e100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7613514</ArticleId><ArticleId IdType="pubmed">31839144</ArticleId></ArticleIdList></Reference><Reference><Citation>Jittamala P., Monteiro W., Smit M.R., Pedrique B., Specht S., Chaccour C.J., et al. A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication? PLoS Negl Trop Dis. 2021;15:e0009144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7968658</ArticleId><ArticleId IdType="pubmed">33730099</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins A.L., Steer A.C., Cranswick N., Gwee A. Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15&#xa0;kg? Arch Dis Child. 2018;103:514&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pubmed">29463522</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann J.C., M&#xf6;&#xdf;ner R., Sch&#xf6;n M.P., Lippert U. Topical scabies therapy with permethrin is effective and well tolerated in infants younger than two months. J Dtsch Dermatol Ges. 2019;17:597&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pubmed">31115965</ArticleId></ArticleIdList></Reference><Reference><Citation>Lobo Y., Wheller L. A narrative review of the roles of topical permethrin and oral ivermectin in the management of infantile scabies. Australas J Dermatol. 2021;62:267&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">34184244</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas C., Rehmus W., Chang A.Y. Treatment practices in the management of scabies in infants younger than two months. Pediatr Dermatol. 2021;38:431&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pubmed">33486822</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan T., Krause V.L., James C., Currie B.J. Crusted scabies; A 2-year prospective study from the Northern Territory of Australia. PLoS Negl Trop Dis. 2020;14:e0008994.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7781478</ArticleId><ArticleId IdType="pubmed">33338053</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison E.J., Middleton J., Lanza S., Cowen J.E., Hewitt K., Walker S.L., et al. Do we know how scabies outbreaks in residential and nursing care homes for the elderly should be managed? A systematic review of interventions using a novel approach to assess evidence quality. Epidemiol Infect. 2019;147:e250.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6805746</ArticleId><ArticleId IdType="pubmed">31496448</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoevesandt J., Carl&#xe9; L., Leverkus M., Hamm H. Control of large institutional scabies outbreaks. J Dtsch Dermatol Ges. 2012;10:637&#x2013;647.</Citation><ArticleIdList><ArticleId IdType="pubmed">22458610</ArticleId></ArticleIdList></Reference><Reference><Citation>Leppard B., Naburi A.E. The use of ivermectin in controlling an outbreak of scabies in a prison. Br J Dermatol. 2000;143:520&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pubmed">10971323</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi G., Porter K. Mass drug administration for endemic scabies: A systematic review. Trop Dis Travel Med Vaccines. 2021;7:21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8247067</ArticleId><ArticleId IdType="pubmed">34193305</ArticleId></ArticleIdList></Reference><Reference><Citation>Romani L., Whitfeld M.J., Koroivueta J., Kama M., Wand H., Tikoduadua L., et al. Mass Drug Administration for Scabies - 2 Years of Follow-up. N Engl J Med. 2019;381:186&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pubmed">31242358</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">33130014</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2021</Year><Month>06</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2173-5778</ISSN><JournalIssue CitedMedium="Internet"><Volume>112</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Actas dermo-sifiliograficas</Title><ISOAbbreviation>Actas Dermosifiliogr (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Slowly Spreading Scabies With a Diagnosis Confirmed by Confocal Reflectance Microscopy: New Technologies for Diagnosis.</ArticleTitle><Pagination><StartPage>271</StartPage><EndPage>273</EndPage><MedlinePgn>271-273</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ad.2019.10.007</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0001-7310(20)30428-2</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Morgado-Carrasco</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Cl&#xed;nic de Barcelona, Universitat de Barcelona, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fust&#xe0;-Novell</LastName><ForeName>X</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Cl&#xed;nic de Barcelona, Universitat de Barcelona, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizo</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Cl&#xed;nic de Barcelona, Universitat de Barcelona, Barcelona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alsina</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Dermatolog&#xed;a, Hospital Cl&#xed;nic de Barcelona, Universitat de Barcelona, Barcelona, Espa&#xf1;a. Electronic address: malsina@clinic.cat.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Nuevas tecnolog&#xed;as para el diagn&#xf3;stico de la escabiosis: sarna de evoluci&#xf3;n t&#xf3;rpida con diagn&#xf3;stico confirmado por microscopia confocal de reflectancia.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Actas Dermosifiliogr (Engl Ed)</MedlineTA><NlmUniqueID>101777537</NlmUniqueID><ISSNLinking>2173-5778</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018613" MajorTopicYN="N">Microscopy, Confocal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012520" MajorTopicYN="N">Sarcoptes scabiei</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012532" MajorTopicYN="Y">Scabies</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049876" MajorTopicYN="Y">Unionidae</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>4</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>11</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>11</Month><Day>1</Day><Hour>20</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33130014</ArticleId><ArticleId IdType="doi">10.1016/j.ad.2019.10.007</ArticleId><ArticleId IdType="pii">S0001-7310(20)30428-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Manual"><PMID Version="1">8234976</PMID><DateCompleted><Year>1993</Year><Month>12</Month><Day>10</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0014-2565</ISSN><JournalIssue CitedMedium="Print"><Volume>193</Volume><Issue>4</Issue><PubDate><Year>1993</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Revista clinica espanola</Title><ISOAbbreviation>Rev Clin Esp</ISOAbbreviation></Journal><ArticleTitle>[Epidemic outbreak of scabies related to a patient with human immunodeficiency virus infection and Norwegian scabies].</ArticleTitle><Pagination><StartPage>155</StartPage><EndPage>158</EndPage><MedlinePgn>155-8</MedlinePgn></Pagination><Abstract><AbstractText>A patient with AIDS was admitted to our hospital because of pruritic and disabling erythroderma, it was treated with Lindane without improvement. Skin biopsy of a crusty lesion showed Sarcoptes scabiei hominis, and the diagnosis of Norwegian scabies was made. After a long and intensive treatment with several drugs, cure was achieved. In the following three months we detected 42 people with scabies, all in some relation with the index case. This feature of high contagiousness of Norwegian scabies in a constant, through the scanty literature we have found; and it is due to its diagnostic and therapeutic problems.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>C&#xe1;rdenes Santana</LastName><ForeName>M A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Servicio de Medicina Interna, Las Palmas Norte de Gran Canaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su&#xe1;rez Ortega</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Jim&#xe9;nez Santana</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Carretero Hern&#xe1;ndez</LastName><ForeName>G</ForeName><Initials>G</Initials></Author><Author ValidYN="Y"><LastName>Artiles Vica&#xed;no</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Melado S&#xe1;nchez</LastName><ForeName>P</ForeName><Initials>P</Initials></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Brote epid&#xe9;mico de escabiosis en relaci&#xf3;n con un paciente con infecci&#xf3;n por el virus de la inmunodeficiencia humana y sarna noruega.</VernacularTitle></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Clin Esp</MedlineTA><NlmUniqueID>8608576</NlmUniqueID><ISSNLinking>0014-2565</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000163" MajorTopicYN="N">Acquired Immunodeficiency Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012532" MajorTopicYN="N">Scabies</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013030" MajorTopicYN="N" Type="Geographic">Spain</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>1993</Year><Month>9</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>1993</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>1993</Year><Month>9</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">8234976</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>